TUMOR, SOLID
Clinical trials for TUMOR, SOLID explained in plain language.
Never miss a new study
Get alerted when new TUMOR, SOLID trials appear
Sign up with your email to follow new studies for TUMOR, SOLID, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy tackles tough tumors
Disease control CompletedThis early-phase trial tested a new drug called BDB001, alone or with another drug (pembrolizumab), in people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check safety and find the best dose. Only one person took part, so res…
Matched conditions: TUMOR, SOLID
Phase: PHASE1 • Sponsor: Eikon Therapeutics • Aim: Disease control
Last updated May 26, 2026 10:00 UTC
-
New combo therapy tackles tough tumors
Disease control CompletedThis early-phase study tested an experimental drug called BDB001, given alone or with another cancer drug (pembrolizumab), in 87 adults with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety and find the best dose. This …
Matched conditions: TUMOR, SOLID
Phase: PHASE1 • Sponsor: Eikon Therapeutics • Aim: Disease control
Last updated May 26, 2026 09:53 UTC
-
Immunotherapy duo shows promise for Hard-to-Treat cancers
Disease control CompletedThis study tested a combination of two immunotherapy drugs (durvalumab and tremelimumab) in 14 adults with recurrent solid tumors that have a high number of genetic mutations. The goal was to see if this treatment could slow cancer growth longer than the patients' previous therap…
Matched conditions: TUMOR, SOLID
Phase: PHASE2 • Sponsor: John L. Villano, MD, PhD • Aim: Disease control
Last updated May 26, 2026 09:52 UTC
-
New antibody combo shows promise in Hard-to-Treat cancers
Disease control CompletedThis early-stage study tested a new drug called HMBD-002, alone or with another drug (pembrolizumab), in 48 adults with advanced solid tumors (like lung or breast cancer) that had stopped responding to standard treatments. The main goals were to check safety, find the best dose, …
Matched conditions: TUMOR, SOLID
Phase: PHASE1 • Sponsor: Hummingbird Bioscience • Aim: Disease control
Last updated May 26, 2026 09:49 UTC
-
Sound waves zap kidney tumors in Needle-Free breakthrough
Disease control CompletedThis trial tested a new device that uses focused sound waves (histotripsy) to break apart solid kidney tumors without any cuts or needles. Twenty adults with small, non-spreading kidney tumors were treated to see if the procedure was safe and could fully cover the tumor. The goal…
Matched conditions: TUMOR, SOLID
Phase: NA • Sponsor: HistoSonics, Inc. • Aim: Disease control
Last updated May 26, 2026 09:35 UTC
-
New drug combo tested for tough cancers
Disease control CompletedThis early-phase study tested a new drug called BDB001, alone or with another drug (atezolizumab), in 40 adults with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check safety and find the best dose. The study is complete, but resu…
Matched conditions: TUMOR, SOLID
Phase: PHASE1 • Sponsor: Eikon Therapeutics • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
Experimental drug BDB001 tested in just one patient with advanced cancer
Disease control CompletedThis early-phase trial tested a drug called BDB001 in people with advanced solid tumors that had stopped responding to standard immunotherapy (PD-1 or PD-L1 blockers). Only one person took part, and the main goal was to see if the tumor shrank. This is not a cure, and more resear…
Matched conditions: TUMOR, SOLID
Phase: PHASE2 • Sponsor: Eikon Therapeutics • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Proton beam machine shows promise in tumor control trial
Disease control CompletedThis study tested a new proton therapy machine (Varian ProBeam) in 47 people with solid tumors. The goal was to see how well it controls tumors and how safe it is within 90 days after treatment. Researchers measured tumor response and tracked any side effects from the radiation.
Matched conditions: TUMOR, SOLID
Phase: NA • Sponsor: Varian, a Siemens Healthineers Company • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New proton therapy machine shows promise in tumor control
Disease control CompletedThis study tested a new proton therapy machine (Varian ProBeam360°) in 47 people with solid tumors. The goal was to see if it could control tumor growth and keep side effects low. Results were compared to a set standard to help get the device approved for use.
Matched conditions: TUMOR, SOLID
Phase: NA • Sponsor: Varian, a Siemens Healthineers Company • Aim: Disease control
Last updated May 15, 2026 11:54 UTC